摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

trans,trans dimethyl bicyclohexyl-4,4'-dicarboxylate

中文名称
——
中文别名
——
英文名称
trans,trans dimethyl bicyclohexyl-4,4'-dicarboxylate
英文别名
cis-cis dimethyl bicyclohexyl-4,4'-dicarboxylate;dimethyl bicyclohexyl-4,4'-dicarboxylate;Dimethyl (1r,1'r,4R,4'R)-[1,1'-bi(cyclohexane)]-4,4'-dicarboxylate;methyl 4-(4-methoxycarbonylcyclohexyl)cyclohexane-1-carboxylate
trans,trans dimethyl bicyclohexyl-4,4'-dicarboxylate化学式
CAS
——
化学式
C16H26O4
mdl
——
分子量
282.38
InChiKey
DSXKHKUXORYHCQ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.6
  • 重原子数:
    20
  • 可旋转键数:
    5
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.88
  • 拓扑面积:
    52.6
  • 氢给体数:
    0
  • 氢受体数:
    4

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    trans,trans dimethyl bicyclohexyl-4,4'-dicarboxylatesodium hydroxide 作用下, 以 乙醇 为溶剂, 反应 10.0h, 以100%的产率得到trans,trans-bicyclohexyl-4,4'-dicarboxylic acid
    参考文献:
    名称:
    cis,cis-and trans,trans-Bicyclohexyl-4,4'-Dicancers的制备和结构验证
    摘要:
    摘要 标题化合物及其甲酯是通过改进的方法制备的。这些分子的立体化学迄今未在文献中证实,已通过核磁共振和 X 射线晶体学分析确定。
    DOI:
    10.1080/00397919508015889
  • 作为产物:
    描述:
    联苯二甲酸二甲酯 在 palladium on activated charcoal 氢气 作用下, 以 溶剂黄146 为溶剂, 反应 0.5h, 以100%的产率得到trans,trans dimethyl bicyclohexyl-4,4'-dicarboxylate
    参考文献:
    名称:
    cis,cis-and trans,trans-Bicyclohexyl-4,4'-Dicancers的制备和结构验证
    摘要:
    摘要 标题化合物及其甲酯是通过改进的方法制备的。这些分子的立体化学迄今未在文献中证实,已通过核磁共振和 X 射线晶体学分析确定。
    DOI:
    10.1080/00397919508015889
点击查看最新优质反应信息

文献信息

  • STABILIZER COMPOUND, LIQUID CRYSTAL COMPOSITION, AND DISPLAY ELEMENT
    申请人:DIC CORPORATION
    公开号:US20180230094A1
    公开(公告)日:2018-08-16
    The present invention provides a compound represented by General Formula (I). The compound according to the present invention prevents the liquid crystal composition from being deteriorated due to light, has high compatibility with the liquid crystal composition, and does not impair the storage stability of the liquid crystal composition, thus the compound is useful as a constituent member of a liquid crystal composition. Since the liquid crystal composition and the liquid crystal display element containing the compound of the present invention exhibit UV resistance and have a high VHR, it is possible to obtain a liquid crystal display element with excellent display quality in which display defects such as burn-in and display unevenness do not occur or are suppressed.
    本发明提供了一种由通式(I)表示的化合物。根据本发明的化合物可以防止液晶组合物因光照而恶化,与液晶组合物具有高兼容性,并不会损害液晶组合物的储存稳定性,因此该化合物作为液晶组合物的组成部分是有用的。由于含有本发明化合物的液晶组合物和液晶显示元件表现出UV抵抗性,并具有高VHR,因此可以获得具有优异显示质量的液晶显示元件,其中不会发生或被抑制烧屏和显示不均匀等显示缺陷。
  • SUBSTITUTED AZOLES, ANTIVIRAL ACTIVE COMPONENT, PHARMACEUTICAL COMPOSITION, METHOD FOR PREPARATION AND USE THEREOF
    申请人:Ivachtchenko Alexandre Vasilievich
    公开号:US20130253008A1
    公开(公告)日:2013-09-26
    The present invention relates to novel azoles, novel antiviral active components of the general formulas 1A and 1B, pharmaceutical composition, antiviral medicament, method for prophylaxis and treatment of viral diseases, particularly caused by hepatitis C viruses (HCV). In general formulas 1A and 1B wherein: solid lines with accompanying dotted lines ( ) represent ordinary bond or double bond, provided that one of them is an ordinary bond, the other one is double bond; X and Y accept various meanings, one of them is—nitrogen, the other—oxygen, sulfur or NH group; R 1 and R 2 —optionally the same radicals selected from 2-(R)- and (S)-substituted N-acyl pyrrolidine derivatives; N-methyl-N-[2-(R) and (S)-substituted 2,2-disubstituted acetamides; methyl[2-(R) and (S)-substituted ((methyl)amino)-(1-oxobutan-2-yl)-2-(R)-] and (S)-iso-propyl)-carbamates. A represents aliphatic C 2 -C 8 biradical; dioxane, cyclo- and bicycloaliphatic, alkyloxyalkyl, alkyloxyalkylenoxyalkyl, alkenyloxyalkyl, alkynyloxyalkyl biradicals and their thioanaloges; aryl and thiophene alkynylcycloalkyl, alkynyldioxane, alkynylaryl, alkylthiophene, alkenylthiophene and alkynylthiophene, alkyloxyaryl, alkenyloxyaryl, alkynyloxyaryl, alkylthioaryl, alkenylthioaryl, alkynylthioaryl, cycloalkylthiophene, aryldioxane and thiophenyldioxane biradicals. B represents: aliphatic C 2 -C 8 radical, including 1, 2 or 3 triple C≡C bonds; aryl and thiophene, alkynylcycloalkyl, alkynyldioxane, alkynylaryl, alkylthiophene, alkenylthiophene and alkynylthiophene, cycloalkylbenzene, 4-cycloalkylbiphenyl, bicycloalkylbenzene, 4-bicycloalkylbiphenyl, cycloalkylthiophene, aryldioxane and thiophenyldioxane radicals.
    本发明涉及新型唑类化合物,通式1A和1B的新型抗病毒活性成分,药物组合物,抗病毒药物,预防和治疗病毒性疾病的方法,特别是由丙型肝炎病毒(HCV)引起的疾病。在通式1A和1B中,其中:实线与伴随虚线()表示普通键或双键,前提是其中一个是普通键,另一个是双键;X和Y接受各种含义,其中一个是氮,另一个是氧、硫或NH基团;R1和R2—可选地选择自2-(R)-和(S)-取代的N-酰基吡咯烷衍生物;N-甲基-N-[2-(R)和(S)-取代的2,2-二取代乙酰胺;甲基[2-(R)和(S)-取代的((甲基)氨基)-(1-氧代丁酰)-2-(R)-]和(S)-异丙基)-氨基甲酸酯。A代表脂肪族C2-C8双基;二氧六环、环和双环脂肪族、烷氧烷基、烷氧烷氧基烷基、烯烃氧烷基、炔烃氧烷基双基及其硫代物;芳基和噻吩炔基环烷基、炔基二氧六环、炔基芳基、烷基噻吩烯烯基、炔基噻吩、烷氧芳基、烯烃氧芳基、炔烃氧芳基、烷硫芳基、烯硫芳基、炔硫芳基、环烷基噻吩、芳基二氧六环和噻吩二氧六环双基。B代表:脂肪族C2-C8基,包括1、2或3个三重键C≡C键;芳基和噻吩、炔基环烷基、炔基二氧六环、炔基芳基、烷基噻吩、烯烃噻吩和炔基噻吩、环烷基苯、4-环烷基联苯、双环烷基苯、4-双环烷基联苯、环烷基噻吩、芳基二氧六环和噻吩二氧六环基。
  • SUBSTITUTED AZOLES, ANTI-VIRAL ACTIVE INGREDIENT, PHARMACEUTICAL COMPOSITION, METHOD FOR THE PRODUCTION AND USE THEREOF
    申请人:Ivachtchenko, Alexandre Vasilievich
    公开号:EP2657231A2
    公开(公告)日:2013-10-30
    The present invention relates to novel azoles, novel antiviral active components of the general formulas 1A and 1B, pharmaceutical composition, antiviral medicament, method for prophylaxis and treatment of viral diseases, particularly caused by hepatisis C viruses (HCV). In general formulas 1A and 1B wherein: solid lines with accompanying dotted lines (---) represent ordinary bond or double bond, provided that one of them is an ordinary bond, the other one is double bond; X and Y accept various meanings, one of them is - nitrogen, the other - oxygen, sulfur or NH group; R1 and R2 - optionally the same radicals selected from 2-(R)- and (S)- substituted N-acyl pyrrolidine derivatives; N-methyl-N-[2-(R) and (S)- substituted 2,2-disubstituted acetamides; methyl[2-(R) and (S)-substituted ((methyl)amino)-(1-oxobutan-2-yl)-2-(R)-] and (S)-iso-propyl)-carbamates. A represents aliphatic C2-C8 biradical; dioxane, cyclo- and bicycloaliphatic, alkyloxyalkyl, alkyloxyalkylenoxyalkyl, alkenyloxyalkyl, alkynyloxyalkyl biradicals and their thioanaloges; aryl and thiophene alkynylcycloalkyl, alkynyldioxane, alkynylaryl, alkylthiophene, alkenylthiophene and alkynylthiophene, alkyloxyaryl, alkenyloxyaryl, alkynyloxyaryl, alkylthioaryl, alkenylthioaryl, alkynylthioaryl, cycloalkylthiophene, aryldioxane and thiophenyldioxane biradicals. B represents: aliphatic C2-C8 radical, including 1,2 or 3 triple C≡C bonds; aryl and thiophene, alkynylcycloalkyl, alkynyldioxane, alkynylaryl, alkylthiophene, alkenylthiophene and alkynylthiophene, cycloalkylbenzene, 4-cycloalkylbiphenyl, bicycloalkylbenzene, 4-bicycloalkylbiphenyl, cycloalkylthiophene, aryldioxane and thiophenyldioxane radicals.
    本发明涉及新型唑类、通式 1A 和 1B 的新型抗病毒活性成分、药物组合物、抗病毒药物、预防和治疗病毒性疾病(尤其是由丙型肝炎病毒(HCV)引起的疾病)的方法。在通式 1A 和 1B 中 其中实线和附带的虚线(----)代表普通键或双键,条件是其中一个是普通键,另一个是双键;X 和 Y 有多种含义,其中一个是氮,另一个是氧、硫或 NH 基团;R1和R2--任选相同的基团,选自 2-(R)-和(S)-取代的 N-酰基吡咯烷衍生物;N-甲基-N-[2-(R)-和(S)-取代的 2,2-二取代乙酰胺;甲基[2-(R)-和(S)-取代的((甲基)氨基)-(1-氧代丁-2-基)-2-(R)-]和(S)-异丙基)-氨基甲酸酯。A 代表脂肪族 C2-C8 双烷基;二噁烷、环脂族和双环脂族、烷氧基烷基、烷氧基烯氧基烷基、 烯氧基烷基、炔氧基烷基双烷基及其硫代类似物;芳基和噻吩炔基环烷基、炔基二氧杂环烷基、炔基芳基、烷基噻吩、烯基噻吩和炔基噻吩、烷氧基芳基、烯基氧基芳基、炔基氧基芳基、烷基硫代芳基、炔基硫代芳基、环烷基噻吩、芳基二氧杂环烷和噻吩二氧杂环烷双烷基。B 代表:脂肪族 C2-C8 自由基,包括 1、2 或 3 个三 C≡C 键;芳基和噻吩、炔基环烷基、炔基二氧杂环烷基、炔基芳基、炔基噻吩、烯基噻吩和炔基噻吩、环烷基苯、4-环烷基联苯、双环烷基苯、4-双环烷基联苯、环烷基噻吩、芳基二氧杂环烷和噻吩二氧杂环烷自由基。
  • Substituted azoles, anti-viral active ingredient, pharmaceutical composition, method for the production and use thereof
    申请人:Alla Chem, LLC.
    公开号:EP2808325A1
    公开(公告)日:2014-12-03
    The present invention relates to novel azoles, novel antiviral active components of the general formula 1A and a pharmaceutical composition for prophylaxis and treatment of viral diseases, particularly caused by hepatisis C viruses (HCV).
    本发明涉及新型唑类、通式 1A 的新型抗病毒活性成分和一种药物组合物,用于预防和治疗病毒性疾病,特别是由丙型肝炎病毒(HCV)引起的疾病。
  • POLYMER COMPRISING CYCLOHEXYLENE GROUPS AND ITS USE IN FILMS WITH NEGATIVE OPTICAL DISPERSION
    申请人:Merck Patent GmbH
    公开号:EP2451893B1
    公开(公告)日:2013-05-29
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物